Navigation Links
HIV Hides Out in Bone Marrow Cells
Date:3/7/2010

Another secret stash of the virus makes it that much harder to eliminate, scientists say

SUNDAY, March 7 (HealthDay News) -- Medications can reduce the level of the AIDS virus in the blood to zero, but HIV doesn't disappear and often roars back when patients stop taking their pills. Now, research is giving scientists new insight into how the virus manages to hide and avoid the killing powers of medicine.

In a new study, researchers report that the virus lurks in certain bone marrow cells and "reawakens" only under certain circumstances.

The research provides a new target for scientists, but it also presents new challenges because killing off bone marrow cells is a dicey proposition.

Overall, the findings provide "a better understanding of how HIV hides in the body" and could lead to better strategies to kill or control it, said study co-author Dr. Kathleen Collins, an associate professor of internal medicine at the University of Michigan.

Doctors have long known about the ability of HIV -- the AIDS virus -- to avoid being killed off completely by medications. Drugs may prevent the virus from infecting new cells, "but they don't get rid of cells that contain the virus and have potential to make new viral particles," Collins said.

This helps explain why HIV isn't curable. The immune systems of patients may be able to control the virus for a time but later fall victim to a renewed attack and, ultimately, to AIDS.

"A patient cannot be cured of HIV until all sources of infection are eliminated," said Jerome A. Zack, director of the UCLA Center for AIDS Research in Los Angeles.

But where does the virus hide when it's not in the blood? Researchers have suspected that the bone marrow -- which creates blood cells -- could serve as the hiding place.

In the new study, published in the March 7 online edition of Nature Medicine, researchers examined bits of AIDS virus and cells from infected people in the laboratory.

The investigators found that the virus can infect certain kinds of bone marrow cells that are the parents ("progenitors") of blood cells, Collins said.

So why not use a medication to kill all those parent cells, thereby perhaps ridding the body of HIV?

It sounds simple, but killing all of these blood-producing marrow cells would be lethal to humans, Collins said. However, "maybe we could find ways of targeting only the latently infected bone marrow cells," she added.

Zack, the UCLA researcher, said the study findings are convincing, but "we as yet do not have easy ways to eliminate these dormant sources of virus. The challenge to the field is to find all sources of virus -- this study identifies one -- and identify ways to eliminate them. Only by developing strategies to eliminate all the different sources can we purge HIV from the body."

In the long run, study co-author Collins said, the findings could help scientists develop ways to eradicate HIV or turn lifelong medication therapy "into a therapy that might last for a defined period of time."

More information

There's more on treating HIV/AIDS at Avert.org.



SOURCES: Kathleen Collins, M.D., Ph.D., associate professor of internal medicine, University of Michigan, Ann Arbor; Jerome A. Zack, Ph.D., director, UCLA Center for AIDS Research, Los Angeles; March 7, 2010, Nature Medicine, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Governors Health Plan Hides the True Cost of a Mandatory Purchase Requirement, Testimony Shows
2. Super-Thin Drug-Free Coating Hides Stent as It Unblocks Heart Arteries
3. Scientists Uncover How HIV Hides Inside Cells
4. FRC Says Planned Parenthood, Desperate to Hide Agenda, Attacks Hatch and Hides Intent
5. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
6. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
7. Oral drug sets a new survival standard for bone marrow cancer
8. Bone marrow cell transplants help nerve regeneration
9. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
10. Transplanted Bone Marrow Cells Aid Nerve Regeneration
11. Stem cells make bone marrow cancer resistant to treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that come ... including the right microorganisms in your diet can actually improve health outcomes. And the good ... is the topic of a new peer-reviewed paper led by Maria Marco, ...
(Date:3/27/2017)... ... 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and ... key role this treatment plays in protecting oral health, along with the benefits of ... who need a root canal in White Plains, NY or their second location in ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO ... Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle ... Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis ... A type of groin injury, it occurs when the muscles around the pelvis ... in and around the lower torso, as well as accompanying tenderness and weakness. ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of ... professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes ... supply chain and value analysis professionals have a ‘seat at the table’ with ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Inc. , a privately held, clinical-stage biopharmaceutical company developing immunogene therapeutics, ... Operating Officer, is scheduled to present a corporate overview at two ... BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 PM ... ... Leaders in Biotech Industry – Friday, April 7, 2017 at 11:20 ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
(Date:3/24/2017)... 24, 2017 Abdominal Aortic Aneurysm Repair Devices Market was valued at ... registering a CAGR of 5.1% from 2016 to 2022. The endovascular stent graft system ... market during the study period. Continue Reading ... ... ...
Breaking Medicine Technology: